X-Ray Crystal Structure of JNK2 complexed with the p38(alpha) Inhibitor BIRB796: Insights into the Rational Design of DFG-out Binding MAP Kinase Inhibitors
Journal Article
·
· Bioorg Med Chem Lett. 20:5217-5220,2010
OSTI ID:1087394
- Research Organization:
- SLAC National Accelerator Lab., Menlo Park, CA (United States)
- Sponsoring Organization:
- USDOE Office of Science (SC)
- DOE Contract Number:
- AC02-76SF00515
- OSTI ID:
- 1087394
- Report Number(s):
- SLAC-REPRINT-2013-143
- Journal Information:
- Bioorg Med Chem Lett. 20:5217-5220,2010, Journal Name: Bioorg Med Chem Lett. 20:5217-5220,2010
- Country of Publication:
- United States
- Language:
- English
Similar Records
Analysis of Imatinib and Sorafenib Binding to p38 Compared with c-Abl and b-Raf Provides Structural Insights for Understanding the Selectivity of Inhibitors Targeting the DFG-Out Form of Protein Kinases
Crystal Structures of Il-2-Inducible T Cell Kinase Complexed With Inhibitors: Insights Into Rational Drug Design And Activity Regulation
Structure-based drug design enables conversion of a DFG-in binding CSF-1R kinase inhibitor to a DFG-out binding mode
Journal Article
·
Fri Jan 01 00:00:00 EST 2010
· Biochemistry
·
OSTI ID:1087394
+3 more
Crystal Structures of Il-2-Inducible T Cell Kinase Complexed With Inhibitors: Insights Into Rational Drug Design And Activity Regulation
Journal Article
·
Tue Jul 16 00:00:00 EDT 2013
· Chem.Biol.Drug Des 76:154,2010
·
OSTI ID:1087394
+11 more
Structure-based drug design enables conversion of a DFG-in binding CSF-1R kinase inhibitor to a DFG-out binding mode
Journal Article
·
Wed Aug 11 00:00:00 EDT 2010
· Bioorg. Med. Chem. Lett.
·
OSTI ID:1087394
+13 more